Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Deal Watch: Appili Gets AiPharma’s Help In Advancing COVID-19 Therapy

Oct 01 2021

• By Joseph Haas

Deal Watch 2021

Related Content

Bio-Thera And Intract Partner For Oral mAb Project

Sep 28 2021

Kelix Bio Acquires Chemi Pharma’s Injectable Oncology Facility

Sep 28 2021

Hikma Buys Injectables Specialist Custopharm In $400m+ Deal

Sep 27 2021

Stada And NTC Ally On MENA Ophthalmic Brands

Sep 21 2021

Celltrion Allies With 180 Life Sciences On Repurposing Biosimilars

Sep 21 2021

Asia Deal Watch: CStone Partners With LegoChem On Novel ADC Candidate

Nov 04 2020

Can Avigan Bite Into Buzzing Indian Favipiravir Market?

Aug 20 2020

Oasmia presses ahead with new water-soluble paclitaxel formulation

Apr 17 2009

Renamed Coave Therapeutics Raises $39m To Fund Its Next-Gen Gene Therapies

Jul 21 2021

Boehringer Ingelheim, Gubra Enter Third Obesity Deal

Mar 02 2021

Novartis Broadens VISION On Radioligands

Jun 07 2021

Union Inks China Deal For Promising Skin Drug Orismilast

Sep 28 2021

ViiV Looks Ahead With Third-Gen Integrase Inhibitor From Shionogi

Sep 28 2021

Driving Menarini's Future With Decisive Steps

Sep 27 2021

Incyte, Syndax Team Up On Chronic GVHD, But Some Uncertainties Remain

Sep 27 2021

How The Pandemic Changed Deal-Making Between Biotechs And Big Pharma

Sep 23 2021

Boehringer Buys Abexxa To Boost Cancer Pipeline

Sep 22 2021

Vifor Clinches Deal For Travere's Rare Kidney Disorder Drug

Sep 16 2021

Provepharm’s CEO Plans Fresh Acquisitions After Raising €120m

Sep 16 2021

Deal Watch: AzurRx Expands GI Pipeline With Buyout Of Partner First Wave

Sep 13 2021

AstraZeneca Goes All In On AL Amyloidosis With Caelum Acquisition

Sep 29 2021

Amicus Spins Out Rare Disease Gene Therapy Pipeline, Raises $200m

Sep 29 2021

Merck Closes In On Acceleron But BMS And Anti-Trust Regulators Could Be Obstacles

Sep 29 2021

Sumitomo, Otsuka Both Stand To Gain From CNS Partnership

Sep 30 2021

Merck’s $11.5bn Acceleron Buy Partially Fills Future Keytruda Revenue Gap

Sep 30 2021

GSK Exits $4.2bn Cancer Drug Deal With Merck KGaA After Multiple Failures

Oct 01 2021

Related Companies

Appili Therapeutics Inc.

AiPharma Global Holdings LLC

Fujifilm Toyama Chemical Co. Ltd.

Dr. Reddy's Laboratories Ltd.

Global Response Aid

BioSenic SA

Implant Therapeutics

Janssen Pharmaceutical Cos.

Gubra ApS

Boehringer Ingelheim GmbH

Theragnostics Ltd.

Novartis AG

Advanced Accelerator Applications SA

Grifols, S.A.

Biotest AG

PNP Therapeutics, Inc.

GeoVax Labs, Inc.

Trigone Pharma, Ltd.

4C Biomed Services Ltd

Celularity, Inc.

Oncternal Therapeutics, Inc.

Vivesto AB

FarmaMondo SA

Coave Therapeutics

Additional Topics

Business Strategies Deals M & A Commercial Deal Watch BioPharmaceutical

More from Deal Watch

More from Deals

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window